Incidence of Venous Thromboembolism and Professional Practices in Brest Area

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02895971

Acronym

EPIGETBO III

Enrollment

1416

Registered

2016-09-12

Start date

2013-03-04

Completion date

2017-06-30

Last updated

2017-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Keywords

Venous Thromboembolism, professional Practices

Brief summary

The aim of this study estimate VTE incidence. Investigators prospectively record all cases of symptomatic pulmonary embolism (PE) and deep vein thrombosis (DVT) of the lower limbs diagnosed between March 1, 2013 and February 28, 2014 in hospitals and in the community.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* symptomatic pulmonary embolism (PE) and deep vein thrombosis (DVT) diagnosis confirmed * Patient living in Brest area from time of diagnosis

Exclusion criteria

* invalid diagnosis * asymptomatic event * Main residence patient out of Brest area.

Design outcomes

Primary

Measure	Time frame	Description
Gathering information about potential factors predisposing Thromboembolic disease and treatments undertaken.	two years after VTE	After two years, all medication given to the patient to treat his initial VTE will be recorded, as well as the ongoing of thromboembolic disease

Countries

France

Outcome results